A novel haplotype in ABCA1 gene effects plasma HDL-C concentration
Tài liệu tham khảo
Abbott, 1988, High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study, Arteriosclerosis, 8, 207, 10.1161/01.ATV.8.3.207
Miller, 1990, Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease, Am J Cardiol, 65, 1, 10.1016/0002-9149(90)90017-U
Miller, 1992, Long-term predictors of subsequent cardiovascular events with coronary artery disease and ‘desirable’ levels of plasma total cholesterol, Circulation, 86, 1165, 10.1161/01.CIR.86.4.1165
Cockerill, 2001, Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation, Circulation, 103, 108, 10.1161/01.CIR.103.1.108
Nofer, 2001, Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids, J Biol Chem, 276, 34480, 10.1074/jbc.M103782200
Nofer, 2002, HDL and arteriosclerosis: beyond reverse cholesterol transport, Atherosclerosis, 161, 1, 10.1016/S0021-9150(01)00651-7
Navab, 2000, Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3, J Lipid Res, 41, 1495, 10.1016/S0022-2275(20)33462-3
Navab, 1998, High density associated enzymes: their role in vascular biology, Curr Opin Lipidol, 9, 449, 10.1097/00041433-199810000-00009
Friedlander, 1986, Biological and environmental sources of variation in plasma lipids and lipoproteins: the Jerusalem Lipid Research Clinic, Hum Hered, 36, 143, 10.1159/000153618
Bucher, 1988, Biological and cultural sources of familial resemblance in plasma lipids: a comparison between North America and Israel—the Lipid Research Clinics Program, Genet Epidemiol, 5, 17, 10.1002/gepi.1370050103
Hunt, 1989, Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins, Am J Epidemiol, 129, 625, 10.1093/oxfordjournals.aje.a115175
Tall, 2001, Genetic disorders affecting plasma high-density lipoproteins, 2915
Bisoendial, 2003, Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein, Circulation, 107, 2944, 10.1161/01.CIR.0000070934.69310.1A
Frikke-Schmidt, 2004, Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population, J Clin Invest, 114, 1343, 10.1172/JCI20361
Cohen, 2004, Multiple rare alleles contribute to low plasma levels of HDL cholesterol, Science, 305, 869, 10.1126/science.1099870
Clee, 2001, Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease, Circulation, 103, 1198, 10.1161/01.CIR.103.9.1198
Singh, 1993, Coronary heart disease in Indians, Pakistanis and Bangladeshis: aetiology and possibilities for prevention, Br Heart J, 69, 572, 10.1136/hrt.69.6.572
Lapicka-Bodzioch, 2001, Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome, Biochim Biophys Acta, 1537, 42, 10.1016/S0925-4439(01)00053-9
Tregouet, 2002, Specific haplotypes of the P-selectin gene are associated with myocardial infarction, Hum Mol Genet, 11, 2015, 10.1093/hmg/11.17.2015
Singaraja, 2003, Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene, Arterioscler Thromb Vasc Biol, 23, 1322, 10.1161/01.ATV.0000078520.89539.77
Drysdale, 2000, Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness, Proc Natl Acad Sci U S A, 97, 10483, 10.1073/pnas.97.19.10483
Costet, 2000, Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor, J Biol Chem, 275, 28240, 10.1074/jbc.M003337200
Chinetti, 2001, PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway, Nat Med, 7, 53, 10.1038/83348
Joseph, 2002, Synthetic LXR ligand inhibits the development of atherosclerosis in mice, Proc Natl Acad Sci U S A, 99, 7604, 10.1073/pnas.112059299
Clee, 2001, Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease, Circulation, 103, 1198, 10.1161/01.CIR.103.9.1198